Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
about
Pharmacotherapy for uveitis: current management and emerging therapy.In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device.Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor EverolimusA comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
P2860
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@ast
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@en
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@nl
type
label
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@ast
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@en
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@nl
prefLabel
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@ast
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@en
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@nl
P2093
P2860
P1476
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
@en
P2093
Arnd Heiligenhaus
Beatrix Zurek-Imhoff
Carsten Heinz
Daniela Rammrath
Maren Hennig
Martin Roesel
P2860
P2888
P304
P356
10.1007/S00417-012-2163-9
P577
2012-10-17T00:00:00Z
P6179
1023977303